Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000234303

Medchemexpress LLC 6-[[6-(1-methylpyrazol-4-yl)-triazolo[4,3-b]pyridazin-3-yl]sulfanyl]quinoline | 1022150-57-7 | ≥98.0% | 1 ML
SDP

Supplier:  Medchemexpress LLC HY1201910MM 1ML

Encompass_Preferred

SGX-523 is a selective, ATP-competitive inhibitor of the MET (c-Met/HGFR) receptor tyrosine kinase used as a research tool to study MET signaling in vitro. It is commonly supplied as concentrated solutions (for example, 10 mM in 1 mL) or as a purified solid for biochemical and cell-based assays.

  • Selective MET inhibitor with low-nanomolar potency.
  • Potent ATP-competitive inhibition (IC50 ≈ 4 nM).
  • Purity ≥98% by HPLC, suitable for research applications.
  • Molecular weight 359.41 g/mol; formula C18H13N7S.
  • Available as small-volume concentrated solutions for in vitro assays.

Catalog No. 50-002-34303


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.